-
Forest Laboratories LLC et al v. Amneal Pharmaceuticals LLC et al DC CAFC
- 1:15-cv-00430
- D. Del.
- Judge: Mitchell S. Goldberg
- Filed: 05/28/2015
- Closed: 07/11/2017
- Latest Docket Entry: 10/20/2020
- PACER
- Docket updated daily
2
Plaintiffs
3
Defendants
1
Accused
Product
1
Patent-in-Suit
776
Days in
Litigation
-
Forest Laboratories LLC et al v. Amneal Pharmaceuticals LLC et al DC CAFC
- 1:15-cv-00430
- D. Del.
- Judge: Mitchell S. Goldberg
- Filed: 05/28/2015
- Closed: 07/11/2017
- Latest Docket Entry: 10/20/2020
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A pharmaceutical composition comprising as a medicinally active compound: trans-5-chloro-2-methyl-2,3,3a, 12b-tetrahydro-1H-dibenzÂ2,3:6,7!oxepinoÂ4,5-c!pyrrole or a pharmaceutically acceptable salt thereof; wherein the composition is a solid
view more
|
Valid
Entry 14 Entry 13 |
2 |
The pharmaceutical composition of claim 1, wherein the composition further comprises a pharmaceutically acceptable water-soluble or water-dispersable carrier material.
|
Valid
Entry 14 Entry 13 |
4 |
A method for treating tension, excitation, anxiety, and psychotic and schizophrenic disorders, comprising administering sublingually or buccally an effective amount of a pharmaceutical composition comprising
view more
|
Valid
Entry 14 Entry 13 |
5 |
The pharmaceutical composition of claim 1, wherein the composition disintegrates within 10 seconds in water at 37.degree. C.
|
Valid
Entry 14 Entry 13 |
6 |
The composition of claim 1, further comprising one or more pharmaceutically acceptable auxiliaries selected from the group consisting of hydrolyzed dextran, dextrin, mannitol, algenates, polyvinyl alcohol, polyvinyl pyrrolidine and water soluble
view more
|
Valid
Entry 14 Entry 13 |
9 |
The method of claim 4, wherein the composition is a solid pharmaceutical composition which rapidly disintegrates in the mouth of a subject upon insertion into the buccal pouch or upon placement under the tongue.
|
Valid
Entry 14 Entry 13 |
10 |
The method of claim 4, wherein the pharmaceutical composition further comprises pharmaceutically acceptable auxiliaries selected from the group consisting of hydrolyzed dextran, dextrin, mannitol, algenates, polyvinyl alcohol, polyvinyl
view more
|
Valid
Entry 14 Entry 13 |
-
Infringement
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Generic Asenapine maleate tablets pursuant to ANDA No. 207307 | US 5,763,476 A |
1, 2, 4, 5, 6, 9, 10
|
Infringement
Entry 14Entry 13 |
Amneal Pharmaceuticals, LLC
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Generic Asenapine maleate tablets pursuant to ANDA No. 207307 | US 5,763,476 A |
1, 2, 4, 5, 6, 9, 10
|
Infringement
Entry 14Entry 13 |
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Generic Asenapine maleate tablets pursuant to ANDA No. 207307 | US 5,763,476 A |
1, 2, 4, 5, 6, 9, 10
|
Infringement
Entry 14Entry 13 |